logo

Stock Screener

Forex Screener

Crypto Screener

VEEV

Veeva Systems Inc. (VEEV)

$

285.03

-1.64 (-0.58%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

8.1411

Market cap

Market cap

47.8 Billion

Price to sales ratio

Price to sales ratio

16.0886

Debt to equity

Debt to equity

0.0129

Current ratio

Current ratio

5.5731

Income quality

Income quality

1.6659

Average inventory

Average inventory

0

ROE

ROE

0.1340



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Veeva Systems Inc. delivers cloud-based software solutions tailored for the life sciences sector across North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company reported depreciation and amortization expenses of $39,383,000.00 reflecting the wear and tear of its assets. Furthermore, it earned an interest income of $207,987,000.00 showcasing its financial investments. The EBITDA is $730,818,000.00 a key indicator of the company's operational profitability, and all financial data pertains to the fiscal year 2025. Additionally, the company incurred an interest expense of $0.00 reflecting its debt servicing obligations. Veeva offers a comprehensive Veeva Commercial Cloud suite, which encompasses a variety of software, data, and analytics solutions like Veeva customer relationship management (CRM) and Veeva Medical CRM, alongside tools such as Veeva CLM, Veeva CRM MyInsights, Veeva CRM Approved Email, Veeva CRM Engage, and Veeva Align, among others. It also provides Veeva Vault for enterprise content and data management, facilitating the management of commercial functions including sales, marketing, medical communications, and research areas such as clinical, regulatory, quality, and safety processes. The company supports clients with professional services that encompass implementation planning, project management, solution design, systems integration, and ongoing managed services, which include outsourced administration. The stock is priced at $277.79 positioning it in the higher-end market, and it boasts a high average trading volume of 1,228,118.00 indicating strong liquidity. With a mid-range market capitalization of $46,718,634,248.00 the company is a steady performer in its field. As a key player in the Medical - Healthcare Information Services industry, Veeva Systems contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. The diverse range of solutions offered underscores its commitment to advancing the life sciences field, making it an essential partner for organizations aiming to enhance their operational efficiencies and deliver impactful results. Veeva Systems Inc., formerly known as Verticals onDemand, Inc., has established itself since its incorporation in 2007 and continues to thrive with its headquarters in Pleasanton, California.

What is Veeva Systems Inc. (VEEV)'s current stock price?

The current stock price of Veeva Systems Inc. (VEEV) is $285.03 as of 2025-10-30. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Veeva Systems Inc. (VEEV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Veeva Systems Inc. stock to fluctuate between $201.54 (low) and $310.50 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-10-30, Veeva Systems Inc.'s market cap is $46,718,634,248, based on 163,907,779 outstanding shares.

Compared to Nvidia Corp, Veeva Systems Inc. has a Lower Market-Cap, indicating a difference in performance.

To buy Veeva Systems Inc. (VEEV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for VEEV. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $2,746,619,000 | EPS: $4.41 | Growth: 34.86%.

Visit https://www.veeva.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $343.96 (2021-08-05) | All-time low: $151.02 (2022-10-14).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

VEEV

zacks.com

Veeva Systems (VEEV) Stock Falls Amid Market Uptick: What Investors Need to Know

Veeva Systems (VEEV) closed the most recent trading day at $283.73, moving 3.07% from the previous trading session.

VEEV

seekingalpha.com

Veeva Systems Inc. (VEEV) Analyst/Investor Day Transcript

Veeva Systems Inc. (NYSE:VEEV ) Analyst/Investor Day October 16, 2025 4:30 PM EDT Company Participants Gunnar Hansen - Director of Investor Relations Peter Gassner - Founder, CEO & Director Brian Van Wagener - Chief Financial Officer Paul Shawah - Executive Vice President of Strategy & Campaign Manager Conference Call Participants Evan Prescott Bailey Saket Kalia - Barclays Bank PLC, Research Division Jeffrey Garro - Stephens Inc., Research Division Hoi-Fung Wong - Oppenheimer & Co. Inc., Research Division Brian Peterson - Raymond James & Associates, Inc., Research Division Andrew DeGasperi - BNP Paribas Exane, Research Division Matthew Shea - Needham & Company, LLC, Research Division Craig Hettenbach - Morgan Stanley, Research Division David Larsen - BTIG, LLC, Research Division Maximillian Persico - RBC Capital Markets, Research Division David Windley - Jefferies LLC, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Charles Rhyee - TD Cowen, Research Division Daragh Regan Presentation Gunnar Hansen Director of Investor Relations Thank you for joining us on the webcast today for our 2025 Investor Day. I'm Gunnar Hansen, Head of Investor Relations here at Veeva.

VEEV

zacks.com

Veeva Systems (VEEV) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Veeva Systems (VEEV) closed at $292.73, indicating a +1.86% shift from the previous trading day.

VEEV

fool.com

This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?

Veeva Systems (VEEV -0.09%) ticks a lot of the boxes that successful growth-seeking investors tend to look for. It boasts a dominant market position, it realizes recurring revenue from sticky subscription services, and it's exposed to the artificial intelligence (AI) megatrend that's reshaping healthcare.

VEEV

zacks.com

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.

VEEV

zacks.com

Veeva Systems (VEEV) Suffers a Larger Drop Than the General Market: Key Insights

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $286.59, denoting a -3.98% move from the preceding trading day.

VEEV

fxempire.com

Big Money Boost – Veeva Up 975% Since 2015

Veeva Systems, Inc. (VEEV) shares soar nearly 1,000% since Big Money's first outlier buy in 2015.

VEEV

youtube.com

Josh Brown's 'Best Stocks in the Market': Veeva Systems

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to detail his latest stock spotlight.

VEEV

prnewswire.com

Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk

Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study BALTIMORE , Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-thirds of data managers and clinical research associates (CRAs) report that inefficiencies in manual data reconciliation, cleaning, and review will put clinical data quality at future risk.

VEEV

seekingalpha.com

Veeva Systems: Top-Line Momentum Should Continue To Accelerate

I reiterate my 'Buy' rating on Veeva Systems, driven by accelerating Vault CRM adoption and robust R&D Solutions growth. VEEV's successful enterprise migrations and a 9-to-3 top-20 pharma win advantage over Salesforce reinforce its industry leadership. The resolution of the IQVIA dispute unlocks full Commercial Cloud potential, removing a major overhang and enabling integrated data solutions.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener